DPP® Syphilis Screen & Confirm Assay
4Pages

DPP® Syphilis Screen & Confirm AssayA Paradigm Shift in Confirmatory Testing for Syphilis Infection A rapid point-of-care test that simultaneously and separately detects treponemal and nontreponemal antibodies. Innovative Design • Screens & confirms syphilis infection simultaneously, no need for reflex testing Easy to Use • Does not require specialized medical training Actionable • Provides results in 15 minutes, enabling physicians to make treatment decisions Cost Effective • Reduces overtreatment rate, healthcare patient visits, and cost burden 0CHEMBIO

About Syphilis Infection & Detection Syphilis is a sexually transmitted disease (STD) caused by the spirochete bacterium Treponema pallidum. According to the World Health Organization, every year about 5.6 million new syphilis infections are acquired.1 The presence of an active syphilis infection can be confirmed by the detection of two distinct anti odies: treponemal and nontreponemal. The presence of treponemal antibodies can b indicate a Treponema pallidum infection, but does not indicate if the infection is active. Presence of nontreponemal antibodies indicates an active infection....

13 well characterized syphilis samples were tested with DPP® Syphilis Screen & Confirm and the results of the Nontreponemal and Treponemal lines were compared with RPR test and TP-PA tests respectively. A 100% concordance of results was seen.* Data from package insert

DPP® Syphilis Screen & Confirm Assay “The sensitivities and specificities of NT and T lines of the Chembio rapid test for syphilis are high, with nearly perfect concordance with the gold standard serology.” Guinard et at., Usefulness in clinical practice of a point-of-care rapid test for simultaneous detection of NT and T pallidum-specific antibodies in patients suffering from documented syphilis, Intl J of STD & AIDS, 2412, 944-50, 2013 “DPP test shows good sensitivity and specificity in detecting treponemal and nontreponemal antibodies in 3 kinds of specimens.” “The dual POC tests...